Kidney Function Tests Market is expected to reach USD 1,312.83 million by 2029

Derangement of any of these functions would result in either decreased excretion of waste products and hence their accumulation in the body or loss of some vital nutrient from the body. Based on the level of these excretory products and nutrients in the urine as well as in blood, we could make an accurate calculation to decipher the efficiency of the kidney to undertake its various functions.

Data Bridge Market Research analyses that the kidney function tests market which was USD 823.68 million in 2021, is expected to reach USD 1,312.83 million by 2029, at a CAGR of 6.00% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read More:

https://www.databridgemarketresearch.com/reports/global-kidney-function-tests-market

Market Definition

Kidney function tests are a group of lab tests that include urine analysis, blood urea nitrogen (BUN), and serum creatinine tests, among others, to examine the normal functioning of the kidneys. They are extremely useful in determining the normal functions of the renal tissues as well as detecting any abnormalities or health anomalies, such as acute/chronic kidney disease, polycystic kidney disease, diabetic nephropathy, kidney failure, and glomerulonephritis. Kidney function tests are blood tests or urine tests that evaluate how well your kidneys are working. Most of the tests measure glomerular filtration rate (GFR). Glomerular filtration rate assesses how efficiently your kidneys clear waste from your system. The main function of the kidney would be the excretion of water-soluble waste products from our body. The kidney has various filtration, excretion, and secretory functions. A group of tests that help to evaluate the function of kidneys to enable early diagnosis and prevention of worsening of disease. Wastes and excess fluid are removed from the blood by healthy kidneys. Blood and urine tests show how well the kidneys are working and how quickly wastes are removed from the body. Urine tests can also detect if the kidneys are leaking excessive amounts of protein, which is a sign of kidney damage.

Global Kidney Function Tests Market Dynamics
Drivers

Technological innovations are driving the market
Rising innovation and technological advancement which is the first systems for treating kidney failure were developed in the 1940's, when it was found that blood could be successfully cleared of toxins and returned to the body using a relatively simple device based on artificial sausage skin wrapped around a wooden frame) will further increase a number of prospects that will drive the growth of the kidney function testing market throughout the course of the above mentioned forecast period.

Development of novel products is also bolstering growth
Rising R&D initiatives for the development of novel products are expected to significantly boost market growth during the forecast period. For instance, in January 2020, Germany-based SphingoTec GmbH launched its IB10 sphingotest penKid, a Point-of-Care (PoC) test for Proenkephalin (penKid). This biomarker enables real-time evaluation of kidney function with a normal blood test. In addition, growing investments in the field of kidney function testing are further expected to fuel the market growth. In January 2020, Sweden-based Elypta AB raised a seed round worth USD 7.0 million to develop the first urine test for kidney cancer.

Opportunities

Government initiatives
Several public-private partnerships are launching initiatives to make kidney disease testing more accessible in key areas. For instance, in July 2020, the National Kidney Foundation (NKF) introduced a new kidney health evaluation measure, specifically for diabetes patients, in collaboration with the National Committee for Quality Assurance (NCQA). The new guidelines recommend that diabetic patients be routinely tested for kidney disease. Such initiatives are expected to foster a favourable environment for market expansion.

GET PDF SAMPLE:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-kidney-function-tests-market

Some of the major players operating in the kidney function tests market are:

Abbott (U.S.)
Akers Biosciences, Inc. (U.S.)
Beckman Coulter, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Eurofins Scientific (Luxembourg)
Boston Heart Diagnostics Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
Home Access Health (U.S.)
Laboratory Corporation of America Holdings (U.S.)
PRIMA Lab SA (Switzerland)
Quest Diagnostics Incorporated (U.S.)
Randox Laboratories Ltd. (U.K.)
Sekisui Diagnostics (U.S.)
Siemens (Germany)
Merck KGaA (Germany)
Siemens Healthcare Private Limited (Germany)
Danaher (U.S.)
Sysmex Corporation (Japan)
Nova Biomedical (U.S.)

More Links:

https://dbmrbuisness.blogspot.com/2023/08/global-corneal-topographers-market.html

https://dbmrbuisness.blogspot.com/2023/08/global-allergic-conjunctivitis-drugs.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.